Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A03307-40 | Other Identifier | ID RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an observational, prospective, monocentric, case-control study. Investigators aim to compare the quality of life and oncological treatment strategy in cancer patients admitted or not in ICU.
Inclusion of cancer patients (cases) at discharge of surgical, cardiovascular and thoracic and medical ICU of the Grenoble Alpes University Hospital.
Cases will be matched with cancer patients identified in oncologist's consultation.
Inclusion of controls from oncologist consultations (2 controls for 1 case) For cases and controls, medical data will be collected at inclusion, 3 and 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cases |
|
| |
| Controls | Cancer patients not admitted in ICU, matched with the cases according to
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Questionnaires | Other | Quality of life questionary: 36-Item Short Form Survey Instrument (36-SF) at 3 and 6 months from inclusion By phone |
|
| Measure | Description | Time Frame |
|---|---|---|
| quality of life questionary 36-item short form survey instrument (36-SF) | score of 0 (poor quality of life) to 100 (very good quality of life) | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| intensity of antitumoral treatment compared to standard treatment | standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer) | 3 months |
| quality of life questionary 36-item short form survey instrument (36-SF) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Lung, head and neck or colorectal cancer admitted in ICU (cases) or not (controls)
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Grenoble Alpes | Grenoble | 38043 | France |
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
score of 0 (poor quality of life) to 100 (very good quality of life) |
| 6 months |
| intensity of antitumoral treatment compared to standard treatment | standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer) | 6 months |
| ECOG - Performance status | From 0 (fully active) to 5 (dead) | 3 months and 6 months |
| Activities of Daily Living | From 0 (dependent ) to 6 (autonomous) | 6 months |
| Hospital Anxiety and Depression Scale | Anxiety scale from 0 (no anxiety) to 21 (anxiety) Depression Scale from 0 (no depression) to 21 (depression) | 3 months and 6 months |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |